Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Dual Therapy vs Bismuth Quadruple Therapy for H. pylori Eradication
NCT05742568Phase 4Completed
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Dec 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esomeprazole, amoxicillin in Helicobacter pylori infection, sponsored by Xijing Hospital of Digestive Diseases. Started Dec 2022; status: completed.
02
Drugs
esomeprazoleamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05742568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05742568.